Court upholds fraud conviction of ex-drug company official

03/5/2013 | Bloomberg Businessweek

A panel of the 9th U.S. Circuit Court of Appeals upheld the fraud conviction of Scott Harkonen, former CEO of InterMune, for distributing misleading information about the clinical trial of Actimmune, a drug he publicized as a lung disease treatment. Three judges rejected the free speech arguments of Harkonen, saying fraudulent speech is not protected by the First Amendment.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC